Despite the impact of the ongoing COVID-19 pandemic, as well as regulatory restrictions surrounding the use of gynecological devices that had been affected by safety-related lawsuits and negative publicity, the Asia Pacific gynecological device market will continue to expand through 2029 due to growing patient awareness of gynecologic treatments in this region. In particular, rising awareness of minimally invasive procedures in China and India, where these techniques have been underpenetrated, will result in increased adoption of associated devices.
This Medtech 360 Report provides high-level market metrics for gynecological devices in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region, across a 10-year period.
- Gynecological Devices - Market Insights - Asia Pacific (Supplemental)
Author(s): Vijjapu Kameswara Rao, MS Pharm; Nidhi Nagrath
Vijjapu Kameswara Rao is a research associate on the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at DRG (Part of Clarivate), specializing in the gynecological device market. Kamesh holds a Bachelor's degree in Pharmaceutical Sciences from the Jawaharlal Nehru Technological University Kakinada and a Master's degree in Pharmaceutical Analysis from the National Institute of Pharmaceutical Education and Research, Mohali.
Nidhi Nagrath is an analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at DRG (Part of Clarivate), specializing in the gastrointestinal endoscopy device and diagnostic imaging system servicing markets. Nidhi holds a Bachelor's degree in Pharmacy from the University of Delhi and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Mohali.